-+ 0.00%
-+ 0.00%
-+ 0.00%

GenSight Biologics Finalizes EUR1 Million Offering of Shares, Warrants

MT Newswires·10/19/2026 00:14:08
Listen to the news
12:14 AM EDT, 10/19/2026 (MT Newswires) -- GenSight Biologics (SIGHT.PA) raised 1 million euros through an offering of shares and warrants to existing shareholders, according to an Oct. 16 release. The French biopharma company issued 2,597,404 ordinary shares, 11,940,300 pre-funded warrants, and 14,537,704 warrants as part of the offering.